Our goal is to develop two biobanks of specimens from patients with COVID-19. The first is a collection of serial blood samples from COVID-19 patients, and the second is collection of serial SARS-CoV-2 samples from infected patients. These two biobanks will be used to provide blood and virus samples to answer critical questions about the clinical course of disease in these patients, including the viral evolution of SARS-CoV-2 in the setting of various treatments, as well as assessing immune responses and biomarkers for outcomes. These will be followed by a convalescent sampling study that will collect blood from patients that have recovered from the infection.
This study is funded by a grant from NUCATs.
Michael G. Ison, MD
Professor of Medicine
Infectious Diseases
Judd F. Hultquist, PhD
Assistant Professor of Medicine
Infectious Diseases
Ramon Lorenzo Redondo, PhD
Research Assistant Professor of Medicine
Infectious Diseases
Egon A. Ozer, MD, PhD
Assistant Professor of Medicine
Infectious Diseases